Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 1897 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act) - Kelly - maternal health
H.R. 4004 - Social Determinants Accelerator Act of 2019 - Bustos - social determinants of health
H.R. 4215 - Excellence in Maternal Health Act of 2019 - Bucshon - maternal health
H.R. 4768 - Home Visiting to Reduce Maternal Mortality and Morbidity Act - David - maternal health
H.R. 4900 - Telehealth Across State Lines Act of 2019 - Roe - telehealth
H.R. 4932 - Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act of 2019 - Thompson - telehealth
H.R. 4995 - Maternal Health Quality Improvement Act of 2019 - Engel - maternal health outcomes
H.R. 5190 - STAR Act - Harder - telemedicine assistance for rural health clinics and health centers
H.R. 5257 - Telehealth Expansion Act of 2019 - Cox - establish FCC telehealth program
H.R. 5473 - Enhance Access to Support Essential Behavioral Health Services Act - Bilirakis - telehealth
H.R. 5640 - Data Mapping to Save Moms' Lives Act - Butterfield - maternal health
H.R. 5681 - Protecting Communities from Hospital Closures Act of 2020 - Boyle - rural health
H.R. 5754 - Rural ER Access Act - Green - rural health
H.R. 5763 - National Telehealth Strategy and Data Advancement Act - Gianforte - telehealth
H.R. 5800 - Ban Surprise Billing Act - Scott - surprise medical bills
H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act of 2020 - Neal - surprise medical bills
H.R. 5916 - Transparent Health Care Pricing Act of 2020 - Gallagher - provider transparency in health care services
H.R. 5924 - To amend the Public Health Service Act to authorize a loan repayment program to encourage specialty medicine physicians to serve in rural communities experiencing a shortage of specialty medicine physicians - McKinley - rural health, loan program
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 - Lowey - COVID-19
H.R. 6132 - Social Determinants for Moms Act of 2020 - McBath - maternal health and social determinants of health
H.R. 6138 - Tech to Save Moms Act - Johnson - maternal health
H.R. 6142 - Black Maternal Health Momnibus Act of 2020 - Underwood - maternal health
H.R. 6143 - Moms MATTER Act of 2020 - Kennedy - maternal health
H.R. 6144 - Kira Johnson Act - Adams - maternal health
H.R. 6165 - Data to Save Moms Act of 2020 - Davids - maternal health
H.R. 6232 - To require the Secretary of Health and Human Services, through the National Disaster Medical System, to provide for certain laboratory reimbursement for diagnostic testing for COVID-19 in uninsured individuals - Cardenas - Federal coverage of COVID-19 related visits and testing for uninsured individuals
H.R. 6261 - To provide for coverage of testing for COVID-19 at no cost sharing for Indians receiving health services through the Indian Health Service - Ruiz - Federal coverage of COVID-19 related visits and testing for Native Americans
H.R. 6351 - Universal Coronavirus Vaccine Act - Harder - COVID-19
H.R. 6379 - Take Responsibility for Workers and Families Act - Lowey - COVID-19
H.R. 6426 - To direct the Secretary of Health and Human Services to establish a program under which loans shall be made to certain health care organizations to assist such organizations with anticipated revenue loss or higher operating costs as a result of the COVID-19 emergency, and for other purposes - Max Rose - costs
H.R. 6437 - Coronavirus Immigrant Families Protection Act - Chu - COVID19
H.R. 6467 - Coronavirus Community Relief Act - Neguse - COVID
H.R. 6468 - To provide for an enhanced Coronavirus relief fund, and for other purposes. - Perlmutter - COVID
H.R. 6474 - Healthcare Broadband Expansion During COVID-19 Act - Eshoo - rural health
H.R. 6487 - ACCESS Act - Schakowsky - telehealth
H.R. 6620 - To authorize grants to address substance use during COVID-19.- Kuster - COVID
H.R. 6634 - Emergency COVID Telehealth Response Act - Axne - telehealth
H.R. 6654 - Emergency COVID Telehealth Response Act -Axne - telehealth
H.R. 6666 - COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act - Rush - COVID
H.R. 6719 - Emergency Medical Supplies Procurement Act - Khanna- COVID
H.R. 6763 - COVID-19 Racial and Ethnic Disparities Task Force Act of 2020 - Kelley - COVID
H.R. 6800 - HEROES Act - Lowey - COVID
H.R. 6881 - Emergency Broadband Connections Act of 2020 - COVID
H.R. 6926 - MIND Act -Boyle - COVID
H.R. 6999 - Coronavirus Mental Health and Addiction Assistance Act of 2020 -Ryan - COVID
H.R. 7017 - Right to Test Act - McHenry - Testing
H.R. 7077 - Community Solutions for COVID-19 Act - Kelley - COVID
H.R. 7190 - Increasing Rural Health Access During the COVID-19 Public Health Emergency Act of 2020 - Torres Small - COVID
H.R. 7205 - Nationwide Dig Once Act of 2020 - Eshoo - broadband
H.R. 7302 - To make high-speed broadband internet service accessible and affordable to all Americans, and for other purposes - Clyburn - Broadband
H.R. 7359 - Accelerating Broadband Connectivity Act of 2020 - Kelley - Broadband
S. 116 - Modernizing Obstetric Medicine Standards Act of 2019 (MOMS Act) - Gillibrand - maternal health
S. 916 - Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAs Act) - Durbin - maternal health
S. 2741 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 - Schatz - telehealth
S. 2885 - Stop Marketing and Revealing the Wearables and Trackers Consumer Health Data Act - Cassidy - consumer health information
S. 2986 - Social Determinants Accelerator Act of 2019 - Young - Social Determinants of Health
S. 3152 - Data Mapping to Save Moms' Lives Act - Rosen - maternal health
S. 3318 - Transparent Health Care Pricing Act of 2020 - Cassidy - disclosure of point-of-sale cash prices
S. 3380 - Patient Safety Improvement Act of 2020 - Whitehouse - data collection and quality improvement
S. 3424 - Black Maternal Health Momnibus Act of 2020 - Harris - maternal health
S. 3437 - Improving Care in Rural America Reauthorization Act of 2020 - Loeffler - rural health
S. 3438 - R-DOCS Reauthorization Act of 2020 - Loeffler - telehealth
S. 3517 - ACCESS Act - Klobuchar - telehealth
S. 3568 - Medical Supply Chain Emergency Act of 2020 - Murphy - expedite acquisition of PPE
S. 3570 - To provide for the expedited procurement of equipment needed to combat COVID-19 under the Defense Production Act of 1950 - Baldwin - expedite acquisition of PPE
S. 3721 - COVID-19 Racial and Ethnic Disparities Task Force Act of 2020 - Harris - COVID
S. 3769 - Right to Test Act - Cruz - Testing
S. 3825 - Coronavirus Mental Health and Addiction Assistance Act of 2020 - Klobuchar - COVID
S. 3828 - Jobs to Fight COVID-19 Act of 2020 - Schatz - COVID
S. 3838 - Health Care Broadband Expansion During COVID-19 Act -Schatz - broadband
S. 3877 - Community Solutions for COVID-19 Act - Booker - COVID
S. 3921 - Emergency Medical Supplies Procurement Act - Sanders - COVID
S. 3951 - Increasing Rural Health Access During the COVID-19 Public Health Emergency Act of 2020 - McSally - COVID
S. 3988 - Enhancing Preparedness through Telehealth Act - Cassidy - Telehealth
S. 4015 - Rural Connectivity Advancement Program Act of 2020 - Thune - Rural
S. 4021 - Accelerating Broadband Connectivity Act of 2020 - Wicker - Broadband
S. 4058 - A bill to authorize grants to address substance use during COVID-19 - Smith - SUD
S. 4059 - A bill to direct the Secretary of Health and Human Services to award grants to States, political subdivisions of States, Indian Tribes and Tribal organizations, community-based entities, and primary care and behavioral health organizations to address behavioral health needs caused by the public health emergency declared with respect to COVID-19 - Smith - Mental Health
S. 4095 - A bill to provide emergency benefits for broadband service during periods relating to COVID-19, and for other purposes - Wyden - Broadband
S. 4103 - A bill to amend title XVIII of the Social Security Act to increase the use of telehealth for substance use disorder treatment - Portman - telehealth
S. 4113 - A bill to amend the Communications Act of 1934 to provide grants to States and Indian Tribes to deploy affordable, high-speed broadband to unserved and underserved areas - Bennett - broadband

Regulatory Issues:
HIPAA administrative simplification issues, including standards for privacy, security, and electronic transactions and code sets (including ICD-10), identifiers including the health plan identifier, enforcement; cybersecurity; FEHBP enrollment data clearinghouse initiative, the enrollment reconciliation process, and a related OPM reimbursement factor for records that cannot be reconciled; issues relating to health insurance plan participation in FEHBP, including contract requirements; issues relating to similarly sized subscriber group (SSSG) and MLR requirements under the FEHBP; implementation of the health savings account provisions of the Medicare Act; issues related to Medicare Secondary Payer requirements; issues related to Patient-Centered Outcomes Research Institute (PCORI) re-authorization; issues related to health care price transparency; issues related to all payor claims databases; issues related to implementation of the National Health Information Infrastructure; electronic health records, personal health records, and similar technologies; issues relating to market consolidation; issues related to hospital and provider consolidation; issues related to trauma-informed care; issues related to medical management; issues relating to quality improvement; issues relating to the national health data stewardship; issues relating to hospital outpatient measurement and reporting; issues relating to COVID-19; issues related to addressing the social determinants of health, including housing, transportation, nutrition, and educational opportunities; prescription drug pricing; telemedicine; rural health; issues related to behavioral health benefits; issues related to Managed Long Term Services and Supports (MLTSS); issues related to the collection of race and ethnicity data; issues related to medical loss ratios; reference pricing; review of rates for reasonableness; preexisting condition insurance plans; issues relating to antitrust; issues relating to surprise medical bills; accountable care organizations; provider non- discrimination; coverage of preventive services; contraceptive coverage; pre-existing condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; issues relating to the annual fee on health insurance providers; health plan automatic enrollment requirements; issues related to qualified health plans including certification and rate filing templates; health insurance market rules; reinsurance, risk corridors, and risk adjustment; dependent coverage; summary of benefits and coverage disclosures; benefit and payment parameters; essential health benefits, actuarial value, and accreditation; NQF reauthorization; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations; issues related to supplemental products; issues related to HIPAA excepted benefits; issues related to short term limited duration products; issues related to the federally-facilitated marketplaces (i.e., Exchanges/formerly referred to as the web portal); issues related to business continuity in relation to pandemics or natural events (e.g., hurricane, tornado, etc.); issues related to association health plans; issues related to cost-sharing reductions (CSRs); issues related to the refundable credit for coverage under a qualified health plan; issues related to small employer group size; issues related to Certificate of Public Advantage; issues relating to veterans health care; issues relating to caregivers; and other issues relating to health care reform implementation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Labor - Dept of (DOL), Treasury - Dept of, White House Office, Federal Trade Commission (FTC), Centers For Disease Control & Prevention (CDC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019 - DelBene - prior authorization in Medicare Advantage
H.R. 3925 - Reducing Barriers to Substance Use Treatment Act - Tonko - Opioids
H.R. 3935 - Protecting Patients Transportation to Care Act - Carter - Medicaid coverage for transportation
H.R. 4453 - Protecting Seniors from Health Care Fraud Act of 2019 - Ruiz -Distributing information to Medicare beneficiaries to prevent fraud
H.R. 4529 - Promoting Access to Broadband Act of 2019 - Maloney - Medicaid
H.R. 4583 - Medicare Extra Rx Higher Eligibility Limits in Part D Act of 2019 - Schneider - prescription drug affordability
H.R. 4620 - More Help for Seniors Act of 2019 - Rose - expand eligibility for low-income subsidies under part D of the Medicare program
H.R. 4621 - Collecting and Analyzing Resources Integral and Necessary for Guidance for Social Determinants Act of 2019 - Blunt Rochester - best practices re social determinants of health
H.R. 4629 - Star Rating for Biosimilars Act - Tonko - biosimilars
H.R. 4632 - Better Transparency in Information for Medicare Beneficiaries Act of 2019 - Kind - provides consumers information regarding premiums under LIS benchmark plans
H.R. 4671 - Helping Seniors Afford Health Care Act - Kim - Medicare affordability and low income beneficiaries
H.R. 5006 - Expanding Access to Inpatient Mental Health Act - Emmer - Medicaid coverage for SUD/mental health for institutionalized
H.R. 5201 - Telemental Health Expansion Act of 2019 - Matsui - Medicare coverage of mental telehealth
H.R. 5232 - Road to Recovery Act - Fitzpatrick - Medicaid and CHIP SUD treatment
H.R. 5693 - Primary Health Services Enhancement Act - Kind - Medicare rural health
H.R. 5808 - Save Rural Communities Act of 2020 - Jodey Arrington - rural emergency medical access services under Medicare
H.R. 5833 - To amend title XVIII of the Social Security Act to permit the use of certain psychological evaluation via telehealth for Medicare coverage of neurostimulation services for the treatment of chronic pain - Latta - Medicare coverage in telehealth
H.R. 5882 - GENE Therapy Payment Act - Schrader - value based care
H.R. 6098 - To amend title XXI of the Social Security Act to allow States to expand income eligibility standards under the Children's Health Insurance Program - Barragan - CHIP eligibility
H.R. 6151 - CARING for Kids Act - Abby Fineknauer - CHIP
H.R. 6179 - Increasing Access to Biosimilars Act of 2020 - Cardenas - payments to providers of biosimilars under Medicare
H.R. 6209 - Reducing Unnecessary Senior Hospitalizations Act of 2020 or the RUSH Act of 2020 -Kuster - Medicare coverage for certain services in hospital emergency departments
H.R. 6244 - To amend titles XVIII and XIX to provide for coverage at no cost sharing of COVID-19 testing under the Medicaid program and Children's Health Insurance Program - Kelly - Medicaid coverage of COVID-19 related visits and testing
H.R. 6263 - To amend title XVIII of the Social Security Act to waive cost sharing under the Medicare program for certain visits relating to testing for COVID-19 -Sarbanes - Medicare coverage of COVID-19 related visits and testing
H.R. 6273 - Protecting Vulnerable Americans in Times of Crisis Act of 2020 - Butterfield - FMAP
H.R. 6311 - Care for COVID-19 Act - Ruiz - COVID-19 cost sharing
H.R. 6336 - Increasing Hospital Capacity to Fight the Coronavirus Act of 2020 - Bishop - Medicare and Medicaid payments during COVID-19 emergency
H.R. 6462 - Emergency Medicaid for Coronavirus Treatment Act - Gallego - Medicaid coverage
H.R. 6511 - Ensuring Vaccination and Treatment Affordability Act - Pappas - COVID
H.R. 6521 - To prohibit the Secretary of Health and Human Services from taking certain actions with respect to Medicaid supplemental payments reporting requirements, and for other purposes - Diaz Barragan
H.R. 6538 - Modernized Medicine Act - Kennedy - Medicaid, Telehealth
H.R. 6539 - Coronavirus Medicaid Response Act - Lee - FMAP
H.R. 6572 - To direct the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to carry out a national campaign to increase awareness and knowledge of COVID-19. - Bilirakis - COVID
H.R. 6583 - To amend title XVIII of the Social Security Act to establish a risk corridor program for Medicare Advantage plans during the COVID-19 emergency, and for other purposes. - Houlahan - COVID
H.R. 6616 - Stronger Medicaid Response to the COVID-19 Pandemic Act - Cardenas - COVID
H.R. 6640 - Medicare Advantage COVID Treatment Act - Mucarsel-Powell - COVID
H.R. 6658 - Insular Area Medicaid Coronavirus Recovery Act - Sablan - FMAP
H.R. 6727 - To hold Medicare beneficiaries harmless for specified COVID-19 treatment services furnished under part A or part B of the Medicare program - Schrier - COVID
H.R. 6744 - Computer and Internet Equity Act - Davis - internet access for Lifeline program
H.R. 6753 - Save Rural Hospitals Act of 2020 - Finkenauer - Medicare hospital payments
H.R. 6792 - Improving Telehealth for Underserved Communities Act of 2020 - Smith - telehealth
H.R. 6797 - CHIPPER Act - Wild - CHIP, COVID
H.R. 6837 - Medicare Accelerated and Advance Payments Improvement Act of 2020 - Schneider - COVID
H.R. 7154 - Outpatient Therapy Modernization and Stabilization Act - Boyle - outpatient therapy services
H.R. 7187 - HEALTH Act of 2020 -Thompson -Smith - telehealth
H.R. 7297 - To amend title XVIII of the Social Security Act to provide for forgiveness of certain accelerated and advance payments under parts A and B of the Medicare program. - Kaptur
H.R. 7338 - To amend title XVIII of the Social Security Act to permit the Secretary of Health and Human Services to waive requirements relating to the furnishing of telehealth services under the Medicare program, and for other purposes. - Cheney - Telehealth
H.R. 7391 - To amend title XVIII of the Social Security Act to remove certain geographic and originating site restrictions on the furnishing of telehealth services under the Medicare program - Sherrill - Telehealth
S. 2846 - Protecting Patients Transportation to Care Act - Isakson - Medicaid coverage of transportation
S. 2911 - Seniors Prescription Drug Relief Act of 2019 - Cassidy - Part D smoothing
S. 3220 - Ensuring Access to Direct Support Professionals Act - Portman - Medicaid coverage in acute care hospitals
S. 3238 - Preventive Home Visit Act - King - preventative home visits
S. 3277 - HCBS Infrastructure Improvement Act - Casey - access to community based services
S. 3353 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 - Cassidy - Medicare coverage of kidney transplant services
S. 3384 - Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 - McSally - Medicare Part D drug pricing negotiation
S. 3399 - FCHIP Extension Act - Tester - rural health
S. 3442 - Care for COVID-19 Act - Booker - COVID-19 cost sharing
S. 3443 - Improving Coverage and Care for Mothers Act - Casey - Medicaid coverage for all pregnant and postpartum women
S. 3447 - RUSH Act of 2020 - Thune - Medicare coverage for certain services in hospital emergency departments
S. 3466 - ACCESS for Biosimilars Act of 2020 - McSally - eliminates cost sharing for biosimilar biological products furnished under part B of the Medicare program
S. 3615 - Rural Community Hospital Demonstration Extension Act of 2020 - Murkowski - rural community hospital demonstration program
S. 3665 - Save Rural Hospitals Act of 2020 - Alexander - Medicare hospital payments
S. 3750 - Medicare Accelerated and Advance Payments Improvement Act of 2020 - Shaheen - COVID
S. 3881 - CHIPPER Act - Casey - CHIP, COVID
S. 3998 - HEALTH Act of 2020 - Hyde-Smith - telehealth
S. 3999 - Mental and Behavioral Health Connectivity Act - King - Mental Health
S. 4108 - A bill to amend title XIX of the Social Security Act to increase Federal support to State Medicaid programs during economic downturns - Casey - FMAP

Regulatory Issues:
Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology, network adequacy and provider directories, encounter data and other data-related issues, and risk adjustment data validation (RADV) audit issues including proposed RADV regulation for MA; bidding and payment issues (including MA rate assumptions, MA coding intensity, MA Secondary Payer issues, Part D reinsurance, Part D low income subsidies, Part D direct and indirect remuneration (DIR), and audits); calendar year 2021 policy and technical regulation for MA and Part D; MA and Part D proposed rule on drug pricing changes for 2020; Part D reform, out of pocket limits; issues related to Medicare for All, Medicare buy-in and public option; CMSs price transparency proposal for direct-to-consumer advertisements; issues relating to 2021 Rate Notice and Call Letter; issues related to MLTSS; issues related to proposed changes to removal of safe harbor protection for rebates (proposed rule); issues relating to COVID-19; issues related to audio-only telehealth; issues related to addressing the social determinants of health, including housing, transportation, nutrition, and educational opportunities; issues related to Medicaid presumptive eligibility and continuous eligibility; issues relating to Medicaid best price; in-home health risk assessments; Medicare Medical Loss Ratio issues; implementation of sequestration under the Medicare Advantage and Part D programs; implications of the health insurer fee for MA and Part D plans; application process, audits to evaluate compliance with MA and Part D program rules, benefit design rules, enrollment rules, requirements for notice and denial forms, marketing materials review and approval, marketing activities, including conduct and compensation of brokers and agents and plan sponsor marketing staff; measurement and oversight of plan performance including Special Needs Plans (SNPs); quality measures, grievance and appeals processes, fraud and abuse compliance including training; contracting issues for Dual Eligible SNPs; Federal preemption of State authority under MA and Part D programs, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, Part D coverage gap discount program, including employer group waiver plan (EGWP) issues, and other operational issues; issues raised by Part D coverage of new specialty drugs, the Part D non-interference policy and related issues (e.g., preferred pharmacy and any willing pharmacy requirements, standards for network pharmacy reimbursement, and policies regarding sponsor negotiation of pharmacy price concessions); issues related to the international price index; issues related to child and maternal health; issues related to Medicaid supplemental and disproportionate share hospital (DSH) funding; issues related to Medicaid funding for territories; issues related to medical management; issues relating to MA supplemental benefits; Medication Therapy Management Program requirements and the Center for Medicare and Medicaid Innovation (CMMI) Demonstration; MA EGWP issues; CMMI's value-based insurance design (VBID) demonstration; Part D requirements for offering basic and enhanced alternative plans; MA and Part D systems issues affecting enrollment and disenrollment processing and payment and other operational issues; issues relating to MA and Part D Star Rating system including measures, the methodology for calculating ratings, and the role of the ratings for payment purposes; implementation of the Affordable Care Act (ACA) and the Bipartisan Budget Act of 2018 changes to the Part D coverage gap; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education Program; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting initiative; issues relating to Medicare coverage policy and national coverage decisions; new payment system for physicians under MACRA, including implications for MA and Part D plans; Medicare clinical trials; Medicare/Medicaid integration for dual eligibles, including implementation of the Capitated Financial Alignment Demonstration and related issues (e.g., quality ratings); Medicaid managed care regulations and policies, including CMS's substantial revisions to the managed care regulations, mental health parity rules, the Medicaid managed care actuarial soundness standard, quality oversight, Medicaid and CHIP Payment and Access Commission (MACPAC), grievance and appeals processes, fraud and abuse compliance, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including block grants, the calculation of the federal medical assistance (federal matching) percentage (FMAP), and intergovernmental transfers (IGTs); coordination of benefits with state Medicaid programs; Medicaid prescription drug cost issues affecting Medicaid health plans including issues raised by Medicaid coverage of new specialty drugs; health plan-related Childrens Health Insurance Program (CHIP) issues, including eligibility and outreach issues and CHIP reauthorization; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including Medicaid managed care organization provider tax issues; standards for electronic prescribing; implementation of Medicaid changes of interest to Medicaid health plans made in the ACA including Medicaid expansion, the managed care organization (MCO) prescription drug rebate provisions, minimum payments to primary care providers (PCPs), interactions between the Medicaid program and health insurance exchanges, and Medicaid and CHIP maintenance of effort (MOE) requirements; implications of the health insurer fee for Medicaid health plans; issues related to Medicaid Managed long-term care including home and community-based waiver services (HCBS); expanding the availability of Medicare Advantage and Medicaid health plan telemedicine programs; implications of the new non-discrimination rules for health plans participating in public programs; issues related to Medigap coverage; issues related to business continuity in relation to pandemics or natural events (e.g., hurricane, tornado, etc.); cybersecurity; provider directories; value-based insurance design models; issues relating to prescription drug price blueprint; Part D prescriber enrollment requirements; Part D recovery audit contractor programs; issues relating to enrollment of beneficiaries with ESRD into MA plans; issues related to health homes for children with medically complex conditions; socioeconomic status impacts on star ratings related to MA and Part D programs; and other issues relating to health care reform implementation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), White House Office, Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code INS

16. Specific lobbying issues

H.R. 748 - CARES Act -Courtney - COVID-19 coverage
H.R. 3630 - No Surprises Act - Pallone - surprise medical billing
H.R. 3784 - Air Ambulance Affordability Act of 2019 - Neguse - air ambulances
H.R. 4223 - Protecting Patients from Surprise Medical Bills Act - Spano - surprise medical billing
H.R. 5121 - Healthcare Cost Transparency Act - Beyer - provider price comparison tool
H.R. 5239 - Prescription Drug Price Reporting Act - Joyce - reporting on drug expenditures and price changes under group health plans
H.R. 5575 - Primary and Behavioral Health Care Access Act of 2020 -Underwood - coverage of primary care and behavioral health visits
H.R. 6005 - Know the Price Act - Malinowski - health plan transparency
H.R. 6173 - Covering Coronavirus Test Act of 2020 - DeGette - COVID-19 testing coverage
H.R. 6193 - Medication Access in Emergencies Act of 2020 - Pappas - coverage of prescription drugs during emergency periods
H.R. 6201 - Families First Coronavirus Response Act - Lowey - includes several provisions related to COVID-19 testing coverage
H.R. 6213 - No Cost for COVID-19 Testing Act - Wilson - COVID-19 testing coverage
H.R. 6214 - To amend title XVIII of the Social Security Act to provide for coverage of testing for COVID-19 at no cost sharing under the Medicare Advantage program - Kind - Medicare Advantage coverage of COVID-19 related visits and testing
H.R. 6222 - Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Schakowsky - coverage of certain new preventative services related to COVID-19
H.R. 6231 - Ensuring Access to COVID-19 Preventive Care Act of 2020 - Bucshon - coverage of certain vaccines and testing services during the COVID-19 emergency
H.R. 6299 - Rapid Coverage of COVID-19 Vaccine Act of 2020 - Courtney - COVID-19 coverage
H.R. 6317 - To provide for special enrollment periods during public health emergencies, coverage of services related to public health emergencies, and for other purposes - Doggett - special enrollment periods in public health emergency
H.R. 6338 - To waive high deductible health plan requirements for health savings accounts -Budd - HDHP coverage during COVID
H.R. 6486 - Care for COVID-19 Act 2.0 -Ruiz - COVID
H.R. 6514 - Worker Health Coverage Protection Act - Scott - COVID
H.R. 6518 - Stop Health Premium Spikes Act of 2020 - Peters - risk corridors
H.R. 6532 - COVID Special Enrollment Act of 2020 - Doggett - COVID
H.R. 6568 - Coverage for COVID-19 Treatment Act of 2020 - Rochester - COVID
H.R. 6644 - To require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for services furnished via telehealth if such services would be covered if furnished in-person during the COVID-19 emergency. -Schrier - COVID
H.R. 6674 - Medicare Crisis Program Act of 2020 -Jayapal - COVID
H.R. 6712 - American Healthshare Plans Act of 2020 - Curtis - health share pools
H.R. 6810 - Health Care Protection Act -Davis - COVID
H.R. 7006 - Improving Care in Home Health Agencies Act - Velazquez - home health services
H.R. 7267 - To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to prohibit a group health plan and a health insurance issuer offering group or individual health insurance coverage from reducing contracted rates, or terminating contracts, with health care providers during a public health emergency. - Porter - ERISA
S. 1531 - STOP Surprise Medical Bills Act - Cassidy-Bennet - surprise medical billing
S. 1948 - Chronic Disease Management Act - Thune - pre-deductible coverage of chronic disease prevention services
S. 2546 - Safe Step Act - Murkowski - Step therapy exceptions
S. 3200 - Chronic Disease Management Act of 2020 - Thune - coverage of chronic disease prevention services
S. 3383 - Continuing Coverage for Preexisting Conditions Act of 2020 -Kennedy - preexisting conditions
S. 3499 - A bill to amend coverage requirements to ensure that no person incurs cost sharing when receiving a test to confirm a COVID-19 infection - Smith - COVID-19 cost -sharing
S. 3505 - A bill to require private health insurance to rapidly cover preventive services and vaccines related to the coronavirus - Jones - rapid COVID-19 coverage
S. 3536 - A bill to provide for special enrollment periods during public health emergencies, coverage of services related to public health emergencies, and for other purposes - Casey - COVID-19 coverage
S. 3610 - American Healthshare Plans Act of 2020 - Paul - health share pools
S. 3631 - Relief for Rural Providers During Emergencies Act - Sasse - COVID
S. 3741 - Health Care at Home Act of 2020 - Smith - COVID
S. 3792 - Tele-Mental Health Improvement Act - Smith - parity
S. 3821 - Affordable Health Care Options Act of 2020 - Loeffler - affordability
S. 3991 - Coronavirus 2019 Special Enrollment Period Act - Duckworth - SEP
S. 4106 - A bill to amend the Public Health Service Act to provide for hospital and insurer price transparency - Braun - price transparency

Regulatory Issues:
Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; disability income insurance enrollment and awareness; issues related to COBRA continuation coverage; issues related to behavioral health benefits; issues related to encouraging impaired workers to stay in/return to the workforce; issues related to expanding long-term care insurance coverage; issues relating to COVID-19; issues related to addressing the social determinants of health, including housing, transportation, nutrition, and educational opportunities; issues relating to Medicaid best price; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; Medigap cross-over claim issues, Medigap coverage, implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials, and other Medigap issues; fraud and abuse issues affecting public and private insurance coverage; issues relating to antitrust; implementation of the Mental Health Parity Act requirements; implementation of the 21st Century Cures Act requirements; summary of benefits and coverage disclosures; prior authorization; accountable care organizations; coverage of preventive services; preexisting condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; health reimbursement accounts; dependent coverage; treatment of expatriate plans; issues related to surprise medical bills; issues related to all payor claims databases; issues related to association health plans; issues related to substance abuse and provider treatment records (42 CFR Part 2); issues related to medical management; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations, non-discriminatory wellness programs; issues related to supplemental products; issues relating to dental coverage; issues relating to proposals for single-payer and Medicare/Medicaid buy-in options; issues related to implementation of the Telephone Consumer Protection Act; issues relating to third party payment of premiums; issues related to cost-sharing reductions (CSRs); issues related to interoperability and price transparency; issues related to the employer market; issues relating to the individual market; and other issues relating to health care reform implementation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Centers For Medicare and Medicaid Services (CMS), White House Office, Treasury - Dept of, Federal Trade Commission (FTC), Congressional Budget Office (CBO)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

H.R. 3 - Lower Drug Costs Now Act of 2019 - Pallone - drug pricing
H.R. 4398 - Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 - Cicilline - drug pricing
H.R. 4906 - Insulin Price Reduction Act - DeGette - insulin costs
H.R. 5444 - Lower Insulin Costs Now Act - Underwood - lowering insulin costs
H.R. 5749 - Affordable Insulin for All Act - Crist - insulin costs
H.R. 6155 - To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products - Grothman - biological products
H.R. 6411 - To require group health plans and health insurance issuers offering group or individual coverage to provide notices relating to prescription drug refills to individuals covered under such plans or coverage who reside in emergency areas during emergency periods - McBath - prescription drug refill notices
H.R. 6649 - Lower Drug Costs for Seniors During COVID-19 Act of 2020 -Schakowsky - COVID
H.R. 6739- Ensuring Seniors' Access to COVID Treatments Act - Casten - COVID
H.R. 7062 - Affordable Insulin for the COVID-19 Emergency Act - Waters - Insulin/COVID
S. 2543 - Prescription Drug Pricing Reduction Act of 2019 - Grassley - Drug pricing
S. 3092 - Expanding Access to Low-Cost Generics Act of 2019 - Smith - 180-day exclusivity period
S. 3166 - Prescription Drug Affordability and Access Act - Booker - prescription drug costs
S. 3781 - PART Act - Peters - transparency

Regulatory Issues:
Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to price of drugs and biologics and proposals to limit high prices; issues related to prescription drug coupons and discount programs; issues relating to vaccines; issues related to drug patents and market exclusivity; issues related to pharmacy benefit managers; issues related to biosimilars; issues related to approval of drugs and biologics; issues relating to opioids; issues relating to COVID-19; issues relating to prescription drug rebates; issues relating to prescription drug price blueprint; direct-to-consumer advertising for prescription drugs; issues related to proposed changes to removal of safe harbor protection for rebates (proposed rule); issues relating to access for investigational drugs; and other issues relating to health care reform implementation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Executive Office of the President (EOP), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

H.R. 3709 - Chronic Disease Management Act of 2019 - Blumenauer - HSAs and HDHPs
H.R. 4651 - American Future Healthcare Act of 2019 - King - amends the Internal Revenue Code to expand health savings accounts
H.R. 4652 - Individual Health Insurance Marketplace Improvement Act - Langevin - Individual Market Reinsurance fund
H.R. 5807 - Know Your Provider Act of 2020 - Larson - provider directory information
H.R. 5809 - Better Information Act of 2020 - Beyer - health insurance membership card
H.R. 5816 - Continuing Care for Patients Act of 2020 - Moore - coverage and provider network status
H.R. 5817 - Fair and Honest Advance Cost Estimate for Patients Act of 2020 - Nunes - health plan transparency
H.R. 5825 - To amend the Internal Revenue Code of 1986 to provide for reporting by certain investors with respect to certain specified medical care providers - Neal - investment in medicine
H.R. 6286 - Health Savings Act of 2020 - Burgess - health savings account
H.R. 6545 - Health Insurance Marketplace Affordability Act of 2020 - Murphy
H.R. 7008 - Family Savings Flexibility Act - Wenstrup - HSA arrangements
S. 3439 - Lower Health Insurance Deductibles Act - Scott - health savings accounts
S. 3539 - A bill to amend the Internal Revenue Code of 1986 to exempt telehealth services from certain high deductible health plan rules - Daines - telehealth
S. 3546 - A bill to waive high deductible health plan requirements for health savings accounts - Cruz - health savings accounts
S. 3924 - A bill to provide tax credits to low- to moderate-income individuals for certain computer and education costs, to direct the Federal Communications Commission to modify the requirements for the Lifeline program to provide increased support, and for other purposes. - Durbin - Lifeline/Medicaid

Regulatory Issues:
Annual insurer provider fees; issues concerning the patient-centered outcomes research fee; employer coverage mandate; W-2 reporting requirements; health reimbursement accounts; deductibility limits for insurer compensation; issues relating to COVID-19; health insurer and employer reporting of health coverage; issues related to implementation of health insurance tax; issues related to the refundable credit for coverage under a qualified health plan; issues related to coverage of chronic conditions in high deductible health plans; issues related to health savings accounts; issues related to the deductibility of employer-sponsored health coverage; issues related to Patient-Centered Outcomes Research Institute (PCORI) re-authorization; issues related to enhancing tax treatment of long-term care insurance; issues related to qualified small employer health reimbursement accounts (QSEHRAs); issues related to implementation of the excise tax on high cost employer-sponsored health coverage; and other issues relating to health care reform implementation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Treasury - Dept of

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address: https://www.ahip.org/board-of-directors/

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes